An analysis of data collected by the National Survey on Drug Use and Health from 2015–2018 found that an estimated 9.68% of Americans reported lifetime psilocybin use despite the psychedelic’s controlled status at the federal level. However, now that recent research has revealed that psychedelics such as psilocybin, ketamine and mescaline have mental health benefits, their popularity has skyrocketed.
Investors are pouring millions of dollars into research to develop psychedelic-assisted therapies, while lawmakers across the country are considering legislation to allow psychedelic use for medical purposes. In the meantime, a market for psilocybin has emerged online that grants Americans across the country access to hallucinogenic drugs despite the market’s relatively gray legal landscape. This gray market bypasses most of the stringent and time-consuming conditions patients have to meet before undergoing psychedelic-assisted therapy.
Furthermore, psychedelic-assisted therapy sessions can be quite costly, and they aren’t accessible to most Americans. But with more people turning to psychedelics to address mental health issues such as depression and anxiety, the online psychedelic market has attracted unscrupulous sellers.
Just like the CBD industry ,which has been infiltrated by plenty of illegal sellers who will overlook quality controls for profit, the online psychedelic market has scam operators who are more interested in making profits than delivering a safe and useful product to their customers.
One risk of buying magic mushrooms online is that some sellers will simply disappear with your money without providing the product or service you paid for. Other sellers will claim that the DEA has confiscated your package en route, refuse to offer a refund and stop communications with you.
Note that you may even face legal consequences for ordering psychedelics online if you live in a location that has not sanctioned their production and sale. Depending on local policies, you may also be subject to potential charges and civil penalties— or no legal consequences whatsoever — if the DEA intercepts a package with small amounts of decriminalized psychedelics.
On top of scams to defraud customers of their money, there is also the question of poor safety control and product quality. There is always a chance that the magic mushrooms you purchased online are low quality, tainted or inefficient.
They may not provide the benefits claimed by the seller and, in some cases, can even harm your health if you consume them incorrectly or in large amounts.
The best way to avoid this outcome is to educate yourself on psilocybin strains along with their potency levels, effects, and interactions with other drugs. You should also acquaint yourself with micro-dosing protocols and the different ways of administering psilocybin Finally, make sure you do exhaustive research on the online psilocybin dispensaries you are considering and only order from reputable sources that have scientific evidence to back their products.
The risks above explain why most advocates prefer that psychedelics are administered in clinical settings, and companies such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) do just that at licensed facilities in different locations.
NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
